EDITORIAL

1. Challenges to addressing the unmet medical needs for immunotherapy targeting cold colorectal cancer

REVIEW

1. Role of ferroptosis in colorectal cancer
2. “Cold” colorectal cancer faces a bottleneck in immunotherapy
3. Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?

MINIREVIEWS

1. Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma
2. Evaluation of polygenic risk score for risk prediction of gastric cancer

ORIGINAL ARTICLE

1. Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin
2. Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study
3. microRNA-627-5p inhibits colorectal cancer cell proliferation,migration and invasion by targeting Wnt2
4. Potent bromodomain and extraterminal domain inhibitor JAB-8263 suppresses MYC expression and exerts anti-tumor activity in colorectal cancer models
5. Prognostic value of claudin 18.2 expression in gastric adenocarcinoma

LETTER TO THE EDITOR

1. Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”